Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hormonal contraception effects on HPA-axis functioning
NL-OMON38821Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Apr 2013
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Open-label trial of tetracosactide hexaacetate, Microgynon 30, ethinylestradiol + levonorgestrel, desogestrel and avatrombopag (3 arms), sponsored by Erasmus MC. Primary endpoints: Serum estradiol response, Serum progesterone response and 7 more. Planned start Apr 2013; status: not yet recruiting.
02
Drugs
tetracosactide hexaacetateMicrogynon 30ethinylestradiol + levonorgestreldesogestrelavatrombopag
Beyond the preview
Go deeper on NL-OMON38821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38821.